ACTINIUM PHARMACEUTICALS, INC. Research and Development Expense
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Research and Development Expense of $5.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-06-30 was $5.38M, a 10.21% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-03-31 was $4.20M, a 45.44% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-12-31 was $4.30M, a 10.68% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-09-30 was $4.25M, a 56.54% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for fiscal 2025 was $21.12M, a 29.69% decline from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for fiscal 2024 was $30.05M, a 22.30% decline from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $38.67M, a 67.15% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $23.14M, a 28.31% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 151 month | Research and Development Expense 154 month | Research and Development Expense 157 month | Research and Development Expense 160 month | Research and Development Expense 163 month | Research and Development Expense 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.38M 10-Q · filed 2026-08-07 | $9.58M 10-Q · filed 2026-08-07 | $13.88M derived: sum of 3 quarters · filed 2026-08-07 | $18.12M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2026-03-31 | $4.20M 10-Q · filed 2026-05-08 | $8.50M derived: sum of 2 quarters · filed 2026-05-08 | $12.75M derived: sum of 3 quarters · filed 2026-05-08 | $17.63M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $8.54M derived: sum of 2 quarters · filed 2026-03-30 | $13.42M derived: sum of 3 quarters · filed 2026-08-07 | $21.12M 10-K · filed 2026-03-30 | ||||||||||
| 2025-09-30 | $4.25M 10-Q · filed 2025-11-14 | $9.13M derived: sum of 2 quarters · filed 2026-08-07 | $16.83M 10-Q · filed 2025-11-14 | $21.64M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-06-30 | $4.88M 10-Q · filed 2026-08-07 | $12.58M 10-Q · filed 2026-08-07 | $17.39M derived: sum of 3 quarters · filed 2026-08-07 | $27.16M derived: sum of 4 quarters · filed 2026-08-07 | ||||||||||
| 2025-03-31 | $7.70M 10-Q · filed 2026-05-08 | $12.51M derived: sum of 2 quarters · filed 2026-05-08 | $22.29M derived: sum of 3 quarters · filed 2026-05-08 | $31.11M derived: sum of 4 quarters · filed 2026-05-08 | ||||||||||
| 2024-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $14.59M derived: sum of 2 quarters · filed 2026-03-30 | $23.41M derived: sum of 3 quarters · filed 2026-03-30 | $30.05M 10-K · filed 2026-03-30 | ||||||||||
| 2024-09-30 | $9.77M 10-Q · filed 2025-11-14 | $18.60M derived: sum of 2 quarters · filed 2025-11-14 | $25.23M 10-Q · filed 2025-11-14 | $33.35M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||
| 2024-06-30 | $8.82M 10-Q · filed 2025-08-08 | $15.46M 10-Q · filed 2025-08-08 | $23.58M derived: sum of 3 quarters · filed 2025-08-08 | $35.20M derived: sum of 4 quarters · filed 2025-08-08 | ||||||||||
| 2024-03-31 | $6.63M 10-Q · filed 2025-05-09 | $14.75M derived: sum of 2 quarters · filed 2025-05-09 | $26.38M derived: sum of 3 quarters · filed 2025-05-09 | $37.46M derived: sum of 4 quarters · filed 2025-05-09 | ||||||||||
| 2023-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $19.74M derived: sum of 2 quarters · filed 2025-03-31 | $30.82M derived: sum of 3 quarters · filed 2025-03-31 | $38.67M 10-K · filed 2025-03-31 | ||||||||||
| 2023-09-30 | $11.62M 10-Q · filed 2024-11-14 | $22.70M derived: sum of 2 quarters · filed 2024-11-14 | $30.55M 10-Q · filed 2024-11-14 | $37.88M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||
| 2023-06-30 | $11.08M 10-Q · filed 2024-08-05 | $18.93M 10-Q · filed 2024-08-05 | $26.26M derived: sum of 3 quarters · filed 2024-08-05 | $33.03M derived: sum of 4 quarters · filed 2024-08-05 | ||||||||||
| 2023-03-31 | $7.85M 10-Q · filed 2024-04-26 | $15.18M derived: sum of 2 quarters · filed 2024-04-26 | $21.95M derived: sum of 3 quarters · filed 2024-04-26 | $26.61M derived: sum of 4 quarters · filed 2024-04-26 | ||||||||||
| 2022-12-31 | $7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $14.10M derived: sum of 2 quarters · filed 2024-03-29 | $18.77M derived: sum of 3 quarters · filed 2024-03-29 | $23.14M 10-K · filed 2024-03-29 | ||||||||||
| 2022-09-30 | $6.77M 10-Q · filed 2023-11-02 | $11.43M derived: sum of 2 quarters · filed 2023-11-02 | $15.80M 10-Q · filed 2023-11-02 | $21.22M derived: sum of 4 quarters · filed 2023-11-02 | ||||||||||
| 2022-06-30 | $4.66M 10-Q · filed 2023-08-14 | $9.03M 10-Q · filed 2023-08-14 | $14.45M derived: sum of 3 quarters · filed 2023-08-14 | $19.16M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||
| 2022-03-31 | $4.37M 10-Q · filed 2023-05-15 | $9.79M derived: sum of 2 quarters · filed 2023-05-15 | $14.49M derived: sum of 3 quarters · filed 2023-05-15 | $18.12M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||
| 2021-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $10.12M derived: sum of 2 quarters · filed 2023-03-31 | $13.76M derived: sum of 3 quarters · filed 2023-03-31 | $18.03M 10-K · filed 2023-03-31 | ||||||||||
| 2021-09-30 | $4.71M 10-Q · filed 2022-11-14 | $8.34M derived: sum of 2 quarters · filed 2022-11-14 | $12.62M 10-Q · filed 2022-11-14 | $17.25M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-06-30 | $3.63M 10-Q · filed 2022-08-12 | $7.91M 10-Q · filed 2022-08-12 | $12.55M derived: sum of 3 quarters · filed 2022-08-12 | $16.33M derived: sum of 4 quarters · filed 2022-08-12 | ||||||||||
| 2021-03-31 | $4.28M 10-Q · filed 2022-05-13 | $8.91M derived: sum of 2 quarters · filed 2022-05-13 | $12.70M derived: sum of 3 quarters · filed 2022-05-13 | $16.21M derived: sum of 4 quarters · filed 2022-05-13 | ||||||||||
| 2020-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $8.43M derived: sum of 2 quarters · filed 2022-03-25 | $11.94M derived: sum of 3 quarters · filed 2022-03-25 | $16.09M 10-K · filed 2022-03-25 | ||||||||||
| 2020-09-30 | $3.79M 10-Q · filed 2021-11-12 | $7.30M derived: sum of 2 quarters · filed 2021-11-12 | $11.45M 10-Q · filed 2021-11-12 | $14.82M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | $3.51M 10-Q · filed 2021-07-30 | $7.66M 10-Q · filed 2021-07-30 | $11.03M derived: sum of 3 quarters · filed 2021-07-30 | $15.86M derived: sum of 4 quarters · filed 2021-07-30 | ||||||||||
| 2020-03-31 | $4.15M 10-Q · filed 2021-05-14 | $7.53M derived: sum of 2 quarters · filed 2021-05-14 | $12.36M derived: sum of 3 quarters · filed 2021-05-14 | $16.36M derived: sum of 4 quarters · filed 2021-05-14 | ||||||||||
| 2019-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $8.20M derived: sum of 2 quarters · filed 2021-03-31 | $12.21M derived: sum of 3 quarters · filed 2021-03-31 | $16.55M 10-K · filed 2021-03-31 | $16.55M 10-K · filed 2020-05-08 | |||||||||
| 2019-09-30 | $4.83M 10-Q · filed 2020-10-23 | $4.83M 10-Q · filed 2019-11-12 | $8.84M derived: sum of 2 quarters · filed 2020-10-23 | $13.18M 10-Q · filed 2020-10-23 | $13.18M 10-Q · filed 2019-11-12 | $18.25M derived: sum of 4 quarters · filed 2020-10-23 | ||||||||
| 2019-06-30 | $4.01M 10-Q · filed 2020-08-14 | $4.01M 10-Q · filed 2019-08-09 | $8.35M 10-Q · filed 2020-08-14 | $8.35M 10-Q · filed 2019-08-09 | $13.42M derived: sum of 3 quarters · filed 2020-08-14 | $17.64M derived: sum of 4 quarters · filed 2020-08-14 | ||||||||
| 2019-03-31 | $4.34M 10-Q · filed 2020-06-29 | $4.34M 10-Q · filed 2019-05-10 | $9.41M derived: sum of 2 quarters · filed 2020-06-29 | $13.63M derived: sum of 3 quarters · filed 2020-06-29 | $16.96M derived: sum of 4 quarters · filed 2020-06-29 | |||||||||
| 2018-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | $9.30M derived: sum of 2 quarters · filed 2020-05-08 | $12.63M derived: sum of 3 quarters · filed 2020-05-08 | $17.09M 10-K · filed 2020-05-08 | ||||||||||
| 2018-09-30 | $4.23M 10-Q · filed 2019-11-12 | $4.22M 10-Q · filed 2018-11-09 | $7.56M derived: sum of 2 quarters · filed 2019-11-12 | $12.02M 10-Q · filed 2019-11-12 | $12.01M 10-Q · filed 2018-11-09 | $15.69M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||
| 2018-06-30 | $3.33M 10-Q · filed 2019-08-09 | $3.33M 10-Q · filed 2018-08-09 | $7.80M 10-Q · filed 2019-08-09 | $7.79M 10-Q · filed 2018-08-09 | $11.47M derived: sum of 3 quarters · filed 2019-08-09 | $16.49M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||
| 2018-03-31 | $4.47M 10-Q · filed 2019-05-10 | $4.46M 10-Q · filed 2018-05-10 | $8.14M derived: sum of 2 quarters · filed 2019-05-10 | $13.16M derived: sum of 3 quarters · filed 2019-05-10 | $17.61M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||
| 2017-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $8.70M derived: sum of 2 quarters · filed 2019-03-15 | $13.15M derived: sum of 3 quarters · filed 2019-03-15 | $17.72M 10-K · filed 2019-03-15 | $17.70M 10-K · filed 2018-03-16 | |||||||||
| 2017-09-30 | $5.03M 10-Q · filed 2018-11-09 | $4.96M 10-Q · filed 2017-11-03 | $9.47M derived: sum of 2 quarters · filed 2018-11-09 | $14.05M 10-Q · filed 2018-11-09 | $13.84M 10-Q · filed 2017-11-03 | $18.28M derived: sum of 4 quarters · filed 2019-03-15 | ||||||||
| 2017-06-30 | $4.45M 10-Q · filed 2018-08-09 | $4.38M 10-Q · filed 2017-08-04 | $9.02M 10-Q · filed 2018-08-09 | $8.88M 10-Q · filed 2017-08-04 | $13.25M derived: sum of 3 quarters · filed 2019-03-15 | $18.94M derived: sum of 4 quarters · filed 2019-03-15 | ||||||||
| 2017-03-31 | $4.57M 10-Q · filed 2018-05-10 | $4.50M 10-Q · filed 2017-05-15 | $8.80M derived: sum of 2 quarters · filed 2019-03-15 | $14.49M derived: sum of 3 quarters · filed 2019-03-15 | $18.64M derived: sum of 4 quarters · filed 2019-03-15 | |||||||||
| 2016-12-31 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $9.91M derived: sum of 2 quarters · filed 2019-03-15 | $14.06M derived: sum of 3 quarters · filed 2019-03-15 | $17.83M 10-K · filed 2019-03-15 | $17.50M 10-K · filed 2017-03-16 | |||||||||
| 2016-09-30 | $5.69M 10-Q · filed 2017-11-03 | $9.83M derived: sum of 2 quarters · filed 2017-11-03 | $13.60M 10-Q · filed 2017-11-03 | $16.39M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2016-06-30 | $4.15M 10-Q · filed 2017-08-04 | $7.91M 10-Q · filed 2017-08-04 | $10.70M derived: sum of 3 quarters · filed 2018-03-16 | $13.53M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2016-03-31 | $3.77M 10-Q · filed 2017-05-15 | $6.55M derived: sum of 2 quarters · filed 2018-03-16 | $9.38M derived: sum of 3 quarters · filed 2018-03-16 | $13.22M derived: sum of 4 quarters · filed 2018-03-16 | ||||||||||
| 2015-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $5.62M derived: sum of 2 quarters · filed 2018-03-16 | $9.45M derived: sum of 3 quarters · filed 2018-03-16 | $13.50M 10-K · filed 2018-03-16 | $13.31M 10-K · filed 2016-03-11 | |||||||||
| 2015-09-30 | $2.83M 10-Q · filed 2016-10-28 | $6.67M derived: sum of 2 quarters · filed 2016-10-28 | $10.71M 10-Q · filed 2016-10-28 | $15.12M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2015-06-30 | $3.84M 10-Q · filed 2016-07-29 | $7.89M 10-Q · filed 2016-07-29 | $12.29M derived: sum of 3 quarters · filed 2017-03-16 | $16.43M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2015-03-31 | $4.05M 10-Q · filed 2016-05-10 | $8.45M derived: sum of 2 quarters · filed 2017-03-16 | $12.60M derived: sum of 3 quarters · filed 2017-03-16 | $14.73M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||
| 2014-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $8.55M derived: sum of 2 quarters · filed 2017-03-16 | $10.68M derived: sum of 3 quarters · filed 2017-03-16 | $12.27M 10-K · filed 2017-03-16 | ||||||||||
| 2014-09-30 | $4.14M 10-Q · filed 2015-10-30 | $3.77M 10-Q · filed 2014-10-31 | $6.27M derived: sum of 2 quarters · filed 2015-10-30 | $7.86M 10-Q · filed 2015-10-30 | $8.24M 10-Q · filed 2014-10-31 | $8.60M derived: sum of 4 quarters · filed 2016-03-11 | ||||||||
| 2014-06-30 | $2.13M 10-Q · filed 2015-08-07 | $2.00M 10-Q · filed 2014-08-12 | $3.72M 10-Q · filed 2015-08-07 | $4.46M 10-Q · filed 2014-08-12 | $4.46M derived: sum of 3 quarters · filed 2016-03-11 | $5.23M derived: sum of 4 quarters · filed 2016-03-11 | ||||||||
| 2014-03-31 | $1.59M 10-Q · filed 2015-05-08 | $2.46M 10-Q · filed 2014-05-12 | $2.33M derived: sum of 2 quarters · filed 2016-03-11 | $3.10M derived: sum of 3 quarters · filed 2016-03-11 | $3.61M derived: sum of 4 quarters · filed 2016-03-11 | $31.55M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | $736.13K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.51M derived: sum of 2 quarters · filed 2016-03-11 | $2.02M derived: sum of 3 quarters · filed 2016-03-11 | $3.11M 10-K · filed 2016-03-11 | $2.67M 10-K · filed 2014-02-28 | $29.09M 10-K · filed 2014-02-28 | ||||||||
| 2013-09-30 | $778.23K 10-Q · filed 2014-10-31 | $1.29M derived: sum of 2 quarters · filed 2014-10-31 | $2.37M 10-Q · filed 2014-10-31 | $3.09M derived: sum of 4 quarters · filed 2014-10-31 | $28.79M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $509.26K 10-Q · filed 2014-08-12 | $1.59M 10-Q · filed 2014-08-12 | $2.31M derived: sum of 3 quarters · filed 2014-08-12 | $3.99M derived: sum of 4 quarters · filed 2014-08-12 | $28.02M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $1.09M 10-Q · filed 2014-05-12 | $1.80M derived: sum of 2 quarters · filed 2014-05-12 | $3.48M derived: sum of 3 quarters · filed 2014-05-12 | $4.08M derived: sum of 4 quarters · filed 2014-05-12 | $27.51M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $717.03K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.39M derived: sum of 2 quarters · filed 2014-02-28 | $3.00M derived: sum of 3 quarters · filed 2014-02-28 | $3.44M 10-K · filed 2014-02-28 | $26.42M 10-K · filed 2013-03-29 | |||||||||
| 2012-09-30 | $1.68M 10-Q · filed 2013-11-14 | $2.28M derived: sum of 2 quarters · filed 2013-11-14 | $2.72M 10-Q · filed 2013-11-14 | |||||||||||
| 2012-06-30 | $601.27K 10-Q · filed 2013-08-13 | $1.05M 10-Q · filed 2013-08-13 | ||||||||||||
| 2012-03-31 | $444.89K 10-Q · filed 2013-05-15 | |||||||||||||
| 2011-12-31 | $323.79K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |